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Abstract
Background: Lifestyle factors such as diet and physical activity have been shown to modify the association
between fat mass and obesity–associated (FTO) gene variants and metabolic traits in several populations;
however, there are no gene-lifestyle interaction studies, to date, among Asian Indians living in India. In this
study, we examined whether dietary factors and physical activity modified the association between two FTO
single nucleotide polymorphisms (rs8050136 and rs11076023) (SNPs) and obesity traits and type 2 diabetes (T2D).
Methods: The study included 734 unrelated T2D and 884 normal glucose-tolerant (NGT) participants randomly
selected from the urban component of the Chennai Urban Rural Epidemiology Study (CURES). Dietary intakes were
assessed using a validated interviewer administered semi-quantitative food frequency questionnaire (FFQ). Physical
activity was based upon the self-report. Interaction analyses were performed by including the interaction terms in the
linear/logistic regression model.
Results: There was a significant interaction between SNP rs8050136 and carbohydrate intake (% energy) (Pinteraction = 0.
04), where the ‘A’ allele carriers had 2.46 times increased risk of obesity than those with ‘CC’ genotype (P = 3.0 × 10−5)
among individuals in the highest tertile of carbohydrate intake (% energy, 71 %). A significant interaction was also
observed between SNP rs11076023 and dietary fibre intake (Pinteraction = 0.0008), where individuals with AA genotype
who are in the 3rd tertile of dietary fibre intake had 1.62 cm lower waist circumference than those with ‘T’ allele carriers
(P = 0.02). Furthermore, among those who were physically inactive, the ‘A’ allele carriers of the SNP rs8050136 had 1.89
times increased risk of obesity than those with ‘CC’ genotype (P = 4.0 × 10−5).
Conclusions: This is the first study to provide evidence for a gene-diet and gene-physical activity interaction
on obesity and T2D in an Asian Indian population. Our findings suggest that the association between FTO
SNPs and obesity might be influenced by carbohydrate and dietary fibre intake and physical inactivity. Further
understanding of how FTO gene influences obesity and T2D through dietary and exercise interventions is
warranted to advance the development of behavioral intervention and personalised lifestyle strategies, which
could reduce the risk of metabolic diseases in this Asian Indian population.
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Background
Metabolic traits such as obesity and type 2 diabetes
(T2D) are generally caused by overconsumption of en-
ergy, sedentary lifestyle and genetic susceptibility [1].
Candidate gene and genome-wide association (GWA)
studies have identified several common genetic variants
associated with obesity and diabetes [1–5]. Of these, the
fat mass and obesity–associated gene (FTO) variants
were found to be consistently associated with obesity-
related traits in several populations and has been the
strongest common genetic predictor of obesity known so
far [1–3, 6–9]. To date, FTO has shown the strongest
association with BMI, where the FTO SNPs increased the
risk of obesity by 1.20–1.32 fold in Europeans [10] and by
1.25 fold in Asians [11]. A recent meta-analysis of data
from eight Indian studies showed that FTO variant,
rs9939609, increased the risk of obesity by 1.15 times,
which is equivalent to BMI increase by 0.30 kg/m2 per ef-
fect allele [6]. Previous study in the South Indian popula-
tion (CURES) has shown that the FTO SNPs (rs1588413
and rs8050136) increased obesity risk by 1.27 and 2.06
times, which is equivalent to BMI increase by 0.33 and
0.54 kg/m2 per effect allele, respectively [7]. The FTO gene
is abundantly expressed in hypothalamus and has been
shown to be involved in the control of satiety/appetite
[12]. Given its role in T2D and obesity [11, 13–16], FTO
was considered as a candidate for our gene-diet/-physical
activity interaction study. Several studies have examined
the influence of lifestyle factors such as diet and physical
activity on the association between FTO variants and
obesity traits [1, 9, 15, 17]; however, there are no studies
to date among Asian Indians living in India.
India has the second largest number of people with
T2D in the world, where 62.4 million people in India
have T2D according to the Indian Council of Medical
Research-INdia DIABetes (ICMR-INDIAB) Study [18].
Asian Indians have unique clinical and biochemical
characteristics that are collectively referred to as the
"South Asian" or "Asian Indian Phenotype" (higher waist
circumference, higher levels of total and visceral fat,
hyperinsulinemia, insulin resistance, and a greater pre-
disposition to diabetes) [19] which confers an increased
susceptibility to diabetes and premature cardiovascular
disease. Although there is a strong genetic component
[20–25], unhealthy diet and physical inactivity have also
been shown to contribute to the increasing prevalence
of metabolic diseases among Asian Indians [26, 27].
Studies in European populations have shown that phys-
ical activity and dietary intake may modify the association
of the FTO variant with obesity-related traits [28, 29]. In-
creased physical activity levels have been shown to attenu-
ate the effect of FTO variant on obesity traits in several
populations [9, 17, 28]; however, FTO-diet interactions
have shown conflicting results, where some studies found
that high energy and fat intakes or low carbohydrate in-
take might strengthen the association of FTO variants
with obesity [30, 31], while others failed to confirm such
interactions [14]. These inconsistencies could be attrib-
uted to differences in the sample size, genetic heterogen-
eity and dietary assessments. In the present study, we
examined whether dietary intake and physical activity
levels modified the association of the two commonly stud-
ied FTO single nucleotide polymorphisms (SNPs) with
obesity-related traits and T2D in 1,618 individuals in the
Chennai Urban Rural Epidemiology Study (CURES).
Methods
Study participants
CURES: The study participants were recruited from the
urban component of the Chennai Urban Rural Epidemi-
ology Study (CURES). CURES is a cross-sectional epi-
demiological study conducted on a representative
sample of the population of Chennai (formerly Madras
city) in Southern India [32]. The methodology of the
study has been published elsewhere [32]. Briefly, in
phase 1, 26,001 individuals were recruited based on a
systematic random sampling technique. Participants
with self-reported diabetes taking drug treatment for
diabetes were classified as “known diabetes”. All individ-
uals with known diabetes (n = 1529) were invited to visit
the center for detailed studies. In addition, every 10th
individual of the 26,001 individuals without known dia-
betes was invited to undergo oral glucose tolerance tests
using a 75-g oral glucose load (dissolved in 250 ml of
water) (Phase 3 of CURES). Those who were confirmed
by oral glucose tolerance test to have 2-h plasma glucose
value ≥ 11.1 mmol/l (200 mg/dl) based on World Health
Organization (WHO) consulting group criteria were
labelled as “newly detected diabetes” and those with 2-h
plasma glucose value < 7.8 mmol/l (140 mg/dl) as being
normal glucose tolerant (NGT) [33]. Informed consent
was obtained from all study participants, and the study
was approved by the Madras Diabetes Research Founda-
tion Institutional Ethics Committee.
Phenotype measurements
Anthropometric measurements including weight, height,
and waist were obtained using standardized techniques.
The BMI was calculated as weight (in kg) divided by the
square of height (in m). Biochemical analyses were done
on a Hitachi-912 Auto Analyzer (Hitachi, Mannheim,
Germany) using kits supplied by Roche Diagnostics
(Mannheim). Fasting plasma glucose (glucose oxidase–
peroxidase method), serum cholesterol (cholesterol
oxidase-phenol-4-amino-antipyrene peroxidase method),
serum triglycerides (glycerol phosphatase oxidase-
phenol-4-amino-antipyrene peroxidase method), and
high-density lipoprotein cholesterol (direct method;
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polyethylene glycol-pretreated enzymes) were measured.
Low-density lipoprotein cholesterol was calculated using
the Friedewald formula [34]. Glycated haemoglobin
(HbA1c) was estimated by high-performance liquid
chromatography using a Variant™ machine (Bio-Rad,
Hercules, CA, USA). Serum insulin concentration was
estimated using an enzyme-linked immunosorbent assay
(Dako, Glostrup, Denmark).
Dietary assessment
Dietary intakes were assessed using a previously validated
and published [35] interviewer administered semi-
quantitative food frequency questionnaire (FFQ) contain-
ing 222 food items to estimate food intake over the past
year and took between 20 and 30 min to complete. The
nutritionists responsible for the data collection were well
trained in the methodology to be used before the field
work started. Individuals were asked to estimate the usual
frequency (number of times per day, week, month or
year/never) and the usual serving size of the portion of the
various food items in the FFQ. Common household mea-
sures such as household cups, bowls, ladles, spoons (for
the cooked foods like vegetables) wedges, circles of differ-
ent diameter and visual atlas of different sizes of fruits
(small, medium, large) were shown to assist the individ-
uals in estimating portions. Information on total energy
intake and macronutrients were obtained using the same
FFQ. A detailed description of the development of FFQ
and the data on reproducibility and validity had been pub-
lished [35]. EpiNu, an in-house database was used to as-
sess the average daily food and nutrient intake including
dietary fibre intake.
Dietary glycemic load of the individual serving was cal-
culated by multiplying the carbohydrate content (grams
per serving) of each food by its glycemic index value. This
glycemic load value was then multiplied by the frequency
of consumption and these products were summed to
obtain average daily dietary glycemic load [36].
Physical activity measurement: Physical activity was
based upon a previously validated self-report question-
naire [37]. Based on exercise, leisure time activities and
job related activities respondents were categorized into
three groups indicating activity level (vigorously active,
moderately active and sedentary). Individuals were graded
as vigorously active if they did leisure time exercise and
had physically demanding work, whereas individuals who
either exercised or had physically demanding work were
categorized as moderately active. All others were catego-
rized as sedentary.
SNP selection and Genotyping
The two commonly studied FTO SNPs (rs8050136 and
rs11076023) were chosen based on their previous associ-
ation with obesity and T2D in the European and South
Asian populations [7, 10, 14, 17, 38]. The SNP
rs8050136 lies in intron 1 of the FTO gene which is
highly conserved across species and is located in the
putative transcriptional factor (Cutl- like 1, CUTL1)
binding site [39]. The rs11076023 SNP is located in the
3′UTR region of the FTO gene and hence it can be
speculated that it might have an effect on the stability of
mRNA and gene expression. The SNPs were genotyped
by polymerase chain reaction on a GeneAmp PCR sys-
tem 9700 thermal cycler (Applied Biosystems, Foster
City, CA). The PCR products were digested with MluCI
(rs8050136) and HinfI (rs11076023) restriction enzymes
(New England Biolabs, Inc., Beverly, MA) and the
digested products were resolved by a 3 % agarose gel
electrophoresis. Based on the analysis of 200 blind
duplicates (20 %), there was 100 % concordance in
the genotyping. Furthermore, a few variants were con-
firmed by direct sequencing with an ABI 310 genetic
analyzer (Foster City, CA). The FTO SNPs were in
Hardy Weinberg equilibrium (P > 0.05).
Statistical analyses
Results from the descriptive analyses are presented as
means and SD for continuous variables and as percentages
for categorical variables. Generalized obesity was defined
according to the World Health Organization Asia Pacific
Guidelines for Asians as non-obese (BMI < 25 kg/m2) and
obese (BMI ≥ 25 kg/m2) [40]. A goodness-of-fit chi-square
test was performed to examine if the observed genotype
counts were in Hardy-Weinberg equilibrium. Student t
test as appropriate was used to compare groups for con-
tinuous variables. Given the low frequency of the rare
homozygotes, dominant model was used (comparing
common homozygotes with the combined group of rare
homozygotes and heterozygotes). The genetic associations
with the continuous and categorical outcomes were exam-
ined using linear and logistic regression models, respect-
ively, adjusting for age and gender. When obesity/BMI
was an outcome, T2D status was adjusted and when T2D
was an outcome, obesity was adjusted in the model, in
addition to age and gender. Participants were divided into
tertiles of carbohydrate intake (% energy) (Means: first ter-
tile, 58 %; second tertile, 65 %; third tertile, 71 %), glycemic
load (Means: first tertile, 188; second tertile, 229; third ter-
tile, 272) and dietary fibres (Means: first tertile, 21 g/d;
second tertile, 31 g/d; third tertile, 44 g/d). Interactions
between each SNP and dietary intake/physical activity
were assessed using linear and logistic regressions and
the likelihood ratio test. The interplay between FTO
variants and dietary intake/physical activity was inves-
tigated by including an interaction term in the regres-
sion models. All analyses were carried out using
STATA, version 13. A P value of less than 0.05 was
considered to be statistically significant.
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Results
In the CURES population, 42 % of the individuals were
overweight/obese (BMI > 25 kg/m2). As shown in Table 1.
Participants with T2D had significantly higher BMI (P <
0.0001), waist circumference (P < 0.001), systolic and
diastolic blood pressures (P < 0.0001), fasting plasma glu-
cose and insulin levels (P < 0.0001), total cholesterol (P <
0.0001), triglycerides (P < 0.0001), high-density (P = 0.001)
and low-density (P < 0.0001) lipoprotein cholesterols and
HbA1c (P < 0.0001). FTO gene variants, rs8050136 and
rs11076023, have been shown to be associated with obes-
ity and T2D, respectively, in the CURES study [7].
Interactions between FTO variants and dietary intake on
obesity traits and T2D
There was a significant interaction between FTO SNP
rs8050136 and carbohydrate intake % energy) (Pinteraction =
0.04) on obesity, where the ‘A’ allele carriers of the SNP
rs8050136 had 2.46 times increased risk of obesity than
those with ‘CC’ genotype (P = 1.0 × 10−5) among individ-
uals in the highest tertile of carbohydrate intake (% energy,
71 %) (Fig. 1). We also found a borderline interaction be-
tween SNP rs8050136 and energy adjusted glycemic load
(Pinteraction = 0.07) on obesity (Additional file 1: Figure S1),
where the ‘A’ allele carriers of the SNP rs8050136 had 2.31
times increased risk of obesity than those with ‘CC’ geno-
type among individuals in the highest tertile of energy
adjusted glycemic load (P = 6.0 × 10−5).
With the SNP rs11076023, we observed a significant
interaction (Pinteraction = 0.0008), where individuals with
‘AA’ genotype who are in the 3rd tertile of dietary fibre
intake (44 g/d) had 1.62 cm decrease in waist circumfer-
ence than those with ‘T’ allele carriers (P = 0.02) (Fig. 2a).
A similar interaction trend, but less stronger, was ob-
served with BMI (Pinteraction = 0.03), where individuals
with ‘AA’ genotype who are in the 3rd tertile of dietary
fibre intake (44 g/d) had 0.50 kg/m2 decrease in BMI
than those with ‘T’ allele carriers (P = 0.07) (Fig. 2b). A
borderline interaction (Pinteraction = 0.09) was also seen,
where the ‘A’ allele carriers of the SNP rs11076023 in the
highest tertile of carbohydrate (% energy, mean: 71 %)
had 1.57 times increased risk of T2D than those with
Table 1 Clinical and biochemical characteristics of the participants from the CURES study
Clinical and biochemical
parameters
Type 2 diabetic subjects (T2DM) Normal glucose tolerance subjects (NGT) P value*
Men Women Men Women
(N = 407) (N = 327) (N = 509) (N = 375)
Age (yrs) 49.59 ± 10.49 50.74 ± 11.47 36.25 ± 11.21 36.54 ± 11.70 <0.0001
BMI (Kg/m2) 26.33 ± 4.37 24.49 ± 3.94 23.57 ± 5.09 22.74 ± 4.25 <0.0001
WC (cm) 90.08 ± 9.95 92.11 ± 9.93 80.76 ± 12.43 83.81 ± 11.85 <0.0001
Obese cases (%) 243.00 (60.00) 139.00 (42.50) 179.00 (35.20) 110.00 (29.40) <0.0001
Fasting plasma glucose (mg/dl) 165.42 ± 73.22 155.71 ± 61.52 84.47 ± 8.36 84.71 ± 8.14 <0.0001
Fasting serum insulin (μIU/ml) 12.68 ± 7.62 10.61 ± 6.95 8.48 ± 5.98 7.48 ± 4.88 <0.0001
Systolic blood pressure (mmHg) 129.91 ± 21.82 128.11 ± 21.72 114.25 ± 17.54 116.25 ± 15.60 <0.0001
Diastolic blood pressure (mmHg) 76.54 ± 12.07 78.03 ± 11.73 71.25 ± 11.38 74.28 ± 11.52 <0.0001
Total serum cholesterol (mg/dl) 209.21 ± 43.71 193.66 ± 39.34 173.35 ± 35.15 171.99 ± 35.91 <0.0001
Fasting serum triglycerides (mg/dl) 179.10 ± 118.48 189.25 ± 145.81 100.88 ± 53.71 123.67 ± 70.97 <0.0001
HDL cholesterol (mg/dl) 43.68 ± 9.76 39.05 ± 8.66 45.47 ± 9.80 40.10 ± 9.49 <0.0001
LDL cholesterol (mg/dl) 131.76 ± 36.19 120.93 ± 33.66 107.90 ± 30.17 107.47 ± 29.78 <0.0001
Glycated Haemoglobin (HbA1c) 8.65 ± 2.39 8.76 ± 2.32 5.54 ± 0.50 5.55 ± 0.49 <0.0001
PAL [Sedentary (%); Moderate (%);
Vigorous (%)]
263 (77.10); 76 (22.30);
2 (0.60)
193 (46.80); 60 (20.10);
45 (15.10)
362 (80.80); 80 (17.90);
6 (1.30)
240 (64.70); 112 (30.20);
19 (5.10)
0.001
Total Carbohydrate energy % 65.50 ± 5.43 64.08 ± 6.27 64.60 ± 5.89 63.09 ± 6.84 0.003
Fat energy % 23.23 ± 4.51 23.58 ± 4.76 23.81 ± 4.79 23.88 ± 4.65 0.05
Protein energy % 11.47 ± 1.20 11.43 ± 1.25 11.25 ± 1.12 11.35 ± 1.25 0.009
Energy adjusted glycemic index 62.76 ± 0.14 62.16 ± 0.18 62.94 ± 0.12 62.65 ± 0.14 0.02
Energy adjusted glycemic load 233.52 ± 1.64 226.12 ± 2.40 231.63 ± 1.74 224.32 ± 0.36 0.41
Dietary fibre (g) 28.62 ± 0.54 34.91 ± 0.69 29.84 ± 0.42 35.73 ± 0.56 0.10
NGT, Normal Glucose Tolerance; BMI, Body Mass Index; WC, Waist Circumference; HDL, High Density Lipoproteins; LDL, Low Density Lipoproteins; PAL, Physical
Activity Level
Data shown are represented as means ± SD, wherever appropriate
*P values for the differences in the means/proportions between Type 2 diabetes cases and NGT participants
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‘TT’ genotype (P = 0.002) (Additional file 1: Figure S2),
while the first (mean: 58 %) and second (mean: 65 %)
tertiles did not show any evidence for an association of
the SNP rs11076023 with T2D.
None of the other interactions between the FTO SNPs
and fat and protein energy percentages, glycemic index
and dietary fibre on obesity traits and T2D were statisti-
cally significant (Pinteraction > 0.05 for all interactions)
(Tables 2 and 3).
Interactions between FTO variants and physical activity
levels on obesity traits and T2D
We observed interactions between the SNP rs8050136
and physical activity on BMI, waist circumference and
obesity (Additional file 1: Figure S3a, b and c). Even
though the overall interaction P values were not statisti-
cally significant (P > 0.11 for all comparisons), sub-group
analysis within each levels of physical activity revealed
stronger associations of the SNP rs8050136 with obesity
traits among those who were physically inactive. Among
those who were physically inactive, the ‘A’ allele carriers
of the SNP rs8050136 had 0.95 kg/m2 per minor allele
increase in BMI (P = 0.002), 3.06 cm per minor allele in-
crease in waist circumference (P = 2 × 10−4) and 1.89
times increased risk of obesity (P = 4.0 × 10−5), compared
to those with ‘CC’ genotype. Given that the overall inter-
action was not significant and the effect was observed
only after stratification based on physical activity levels,
we tested for the association between the SNP and phys-
ical activity levels to avoid spurious interaction effects
due to collider bias [41]. There was no association
between the SNP rs8050136 and physical activity
levels (P = 0.53) suggesting that the observed inter-
action is not spurious.
We also observed a statistically significant inter-
action of the SNP rs8050136 with physical activity on
T2D (Pinteraction = 0.003) (Table 4). None of the other
interactions with physical activity levels on obesity traits
and T2D were statistically significant (Pinteraction > 0.05 for
all interactions).
Discussion
Our study provides the first gene-diet interaction data on
obesity-related traits and T2D in an Asian Indian popula-
tion. The present study shows that carbohydrate and diet-
ary fibre intake may modify the association of the FTO
SNPs, rs8050136 and rs11076023, with obesity traits, with
the effect of the SNP being more pronounced among
those who consumed high levels of carbohydrate and diet-
ary fibre. The study also provides evidence that low levels
of physical activity may accentuate the risk of obesity by
the FTO SNP rs8050136. Given the high prevalence of
T2D in South Asia and as 28–44 % of Asians carry at least
one copy of the FTO risk allele [11], our findings hold sig-
nificant implications for public health.
While carbohydrates do not constitute the bulk of the en-
ergy in the West (~45 %) [42], the diet is high in carbohy-
drates among South Asian countries such as India (65.6 %)
[36, 43]. Furthermore, higher dietary carbohydrates and gly-
cemic load have been shown to be associated with the risk
Fig. 1 Interaction of the FTO gene polymorphism (rs8050136) with carbohydrate energy percentage on obesity. The ‘A’ allele carriers (XA = CA +
AA) who are in the 3rd tertile of carbohydrate energy percentage have 2.46 times increased risk of obesity (P = 1.0 × 10−5). *Odds ratio adjusted
for age, gender and diabetes
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of T2D among urban south Indians [43]. In the present
study, we found a significant interaction between the FTO
SNP rs8050136 and carbohydrate energy percentage on
obesity, where the minor allele carriers had higher risk of
obesity among those in the highest tertile of carbohydrate
energy percentage. While our findings are in contrast to
the large European studies which failed to find an inter-
action between FTO and dietary carbohydrate intake on
obesity [14, 44, 45], a study in 4,895 Swedish individuals
[30] showed a significant interaction (Pinteraction = 0.0004);
however, the effect allele of the FTO SNP rs9939609 (strong
LD with rs8050136) increased the risk of obesity among
those with low carbohydrate and high fat intakes. In the
present study, the total carbohydrate intake was much
higher (first tertile, 276 g/d; third tertile, 560 g/d)
compared with that reported in the Western population
(first quintile, 162 g/d; fifth quintile, 238 g/d) [46] and in
another Asian population (first quintile, 233.3 g/d; fifth
quintile, 321.9 g/d) [47]. This might be one of the reasons
why the previous European studies on obesity failed to
identify an interaction with carbohydrate intake and also
this finding partly explains the role of varying dietary pat-
terns in contributing to the heterogeneity in identifying
and replicating gene-diet interactions.
The positive interaction that was observed between
SNP rs11076023 and dietary fibre intake on BMI and
waist circumference in our study (mean dietary fibre in-
take, our study: ~32 g/d) is consistent with the previous
report from the Finnish Diabetes Prevention Study
(mean dietary fibre intake, Finnish: ~20 g/d) [48], where
Fig. 2 a Interaction of the FTO gene polymorphism (rs11076023) with dietary fibre intake on waist circumference. The individuals with AA genotype
who are in the 3rd tertile of dietary fibre intake have 1.62 cm decrease in waist circumference compared to those with ‘T’ allele carriers (P = 0.02).
b Interaction of the FTO gene polymorphism (rs11076023) with dietary fibre intake on body mass index. The individuals with AA genotype who are
in the 3rd tertile of dietary fibre intake have 0.50 kg/m2 decrease in body mass index compared to those with ‘T’ allele carriers (P = 0.07)
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higher BMI was observed in those who had a diet low in
dietary fibre. Furthermore, a recent study from the
CURES also showed an inverse association between diet-
ary fibre intake and cardiovascular disease (CVD) risk
factors among those with T2D, where individuals who
consumed dietary fibre <29 g/d had a higher levels of
total and LDL cholesterol [49]. In our study, the inter-
action between dietary fibre intake and SNP rs11076023
was more pronounced on waist circumference than on
BMI, which suggests that effects are likely to be on cen-
tral obesity rather than obesity per se. This was indeed
shown in another Asian (Japanese) population where
dietary fibre intake was associated with reduced preva-
lence of abdominal obesity after multivariate adjust-
ments including obesity in 4,399 individuals [50].
The prevalence of physical inactivity among South
East Asians (17 %) has been shown to be lower than that
of Europeans (34.8 %) [51]. However, a recent study in
14,227 individuals has shown that 54.4 % of the Indian
population is physically inactive [26]. Significant inter-
action between FTO and physical inactivity on obesity
has been reported in several studies from Europe and
Asia [9, 17]; however, there are no studies, to date,
among Asian Indians living in India. In the present
study, we found that among those who were physically
inactive, the minor allele carriers of the FTO SNP
rs8050136 had higher risk of obesity. Our finding is
in accordance with the previous large studies among
Europeans [9, 17] where physical activity was shown
to attenuate the risk of FTO risk allele on obesity.
Our study has several limitations. We performed a
cross-sectional study and hence, we are unable to infer
causality between the consumption of carbohydrate-rich
foods/physical inactivity and development of obesity.
Although confounders were adjusted in all our analyses,
residual confounding due to unknown factors cannot be
excluded. Interactions were significant only with total
carbohydrate intake (energy %) but not when split as total
and added sugars and refined and whole cereals (data not
shown). Even though our study has a small sample size
compared to the large European cohorts, we were still able
to confirm the previously reported interactions between
FTO variants and dietary intake and physical activity on
obesity traits in this Asian Indian population. The small
sample size might be one of the reasons why there was no
consistency in the gene–diet interactions, where SNP
rs8050136 showed an interaction with carbohydrate intake
(energy %) while SNP rs11076023 showed an interaction
Table 2 Interaction of the FTO SNP (rs8050136) with dietary factors on BMI, obesity, waist circumference and Type 2 diabetes
SNP * Fat energy
percentage
SNP * Protein energy
percentage
SNP * Carbohydrate energy
percentage
SNP * energy adjusted
glycemic load
SNP * energy adjusted
glycemic index
SNP * dietary fibre
Beta coefficients ± standard error (Pinteraction)
¥ for interaction on BMI
−0.06 ± 0.06 (0.27) −0.16 ± 0.23 (0.49) 0.02 ± 0.04 (0.67) 0.002 ± 0.007 (0.81) 0.05 ± 0.09 (0.60) −0.01 ± 0.02 (0.55)
Beta coefficients ± standard error (Pinteraction)
¥ for interaction on obesity
−0.05 ± 0.03 (0.07) −0.11 ± 0.11(0.29) 0.04 ± 0.02 (0.04) 0.005 ± 0.003 (0.08) 0.05 ± 0.04 (0.21) −0.008 ± 0.01 (0.45)
Beta coefficients ± standard error (Pinteraction)
¥ for interaction on waist circumference
−0.14 ± 0.14 (0.34) −0.27 ± 0.57 (0.64) 0.04 ± 0.11 (0.68) 0.004 ± 0.02 (0.83) 0.20 ± 0.23 (0.38) −0.03 ± 0.06 (0.57)
Beta coefficients ± standard error (Pinteraction)** for interaction on Type 2 diabetes
0.01 ± 0.03 (0.73) −0.03 ± 0.12 (0.78) 0.007 ± 0.02 (0.73) 0.00008 ± 0.003 (0.98) −0.02 ± 0.05 (0.70) 0.03 ± 0.01 (0.01)
¥P values adjusted for age, gender and type 2 diabetes
**P values adjusted for age, gender and obesity
Table 3 Interaction of the FTO SNP (rs11076023) with dietary factors on BMI, obesity, waist circumference and Type 2 diabetes
SNP * Fat energy
percentage
SNP * Protein energy
percentage
SNP * Carbohydrate energy
percentage
SNP * energy adjusted
glycemic load
SNP * energy adjusted
glycemic index
SNP * dietary fibre
Beta coefficients ± standard error (Pinteraction)
¥ for interaction on BMI
0.009 ± 0.04 (0.79) 0.10 ± 0.14 (0.44) 0.004 ± 0.03 (0.89) 0.003 ± 0.004 (0.52) 0.03 ± 0.06 (0.57) −0.03 ± 0.01 (0.03)
Beta coefficients ± standard error (Pinteraction)
¥ for interaction on obesity
0.0004 ± 0.01 (0.98) −0.04 ± 0.06 (0.50) 0.004 ± 0.01 (0.74) 0.001 ± 0.002 (0.59) 0.01 ± 0.03 (0.59) −0.01 ± 0.007 (0.17)
Beta coefficients ± standard error (Pinteraction)
¥ for interaction on waist circumference
−0.12 ± 0.0.09 (0.18) −0.32 ± 0.34 (0.34) 0.11 ± 0.07 (0.12) 0.02 ± 0.01 (0.04) 0.25 ± 0.14 (0.08) −0.12 ± 0.04 (0.0008)
Beta coefficients ± standard error (Pinteraction)** for interaction on Type 2 diabetes
−0.03 ± 0.02 (0.15) −0.08 ± 0.07 (0.27) 0.02 ± 0.01 (0.09) 0.003 ± 0.002 (0.16) 0.02 ± 0.03 (0.53) −0.007 ± 0.007 (0.39)
¥P values adjusted for age, gender and type 2 diabetes
**P values adjusted for age, gender and obesity
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with dietary fibre. However, we cannot rule out the fact
that complex traits such as obesity are caused by multiple
gene variants and lifestyle factors and hence, it is not ne-
cessary for all the variants in the gene to show interaction
with the same dietary factor. Given the questionnaire
based assessment of physical activity levels, measurement
error cannot be completely excluded. Finally, even though
we adjusted for age in all the analyses, it is possible that
the unmatched age in cases and controls can introduce a
bias in the study. Two main strengths of our study is the
validated FFQ, which has shown high reproducibility and
validity for total carbohydrates, dietary fibre, glycemic
index and glycemic load, and the analysis of interactions
in a well characterised population.
Conclusions
In summary, this is the first study to provide evidence for
a gene-diet and gene-physical activity interaction on obes-
ity and T2D in an Asian Indian population. Our findings
suggest that the effect of the FTO SNPs, rs8050136 and
rs11076023, on obesity is influenced by high carbohydrate
and dietary fibre intakes and low physical activity levels.
Given that India leads the world in diabetes [52], our
study highlights the need to consume foods with low
carbohydrate content and high dietary fibre and to in-
crease physical activity levels, as these could substantially
reduce the genetic risk of obesity and diabetes. Further
understanding of how FTO gene influences obesity and
T2D through dietary and exercise interventions is war-
ranted to advance the development of behavioral interven-
tion and personalised lifestyle strategies, which could
reduce the risk of metabolic diseases in this Asian Indian
population.
Additional file
Additional file 1: Figure S1: Interaction of the FTO gene polymorphism
(rs8050136) with energy adjusted glycemic load on obesity. The ‘A’ allele
carriers had 2.31 times increased risk of obesity than those with ‘CC’
genotype among individuals in the highest tertile of energy adjusted
glycemic load (P=6.0x10-5). Figure S2: Interaction of the FTO gene
polymorphism (rs11076023) with carbohydrate energy percentage on
Type 2 diabetes. The ‘A’ allele carriers who are in the 3rd tertile of
carbohydrate energy percentage have 1.66 times increased risk of Type 2
diabetes (P=0.002). *Odds ratio adjusted for age, gender and obesity.
Figure S3a: Interaction of the FTO gene polymorphism (rs8050136) with
physical activity level on body mass index (BMI). The ‘A’ allele carriers
who are physically inactive have 0.95 kg/m2 increase in BMI compared to
those with ‘C’ allele carriers (P = 0.002). Figure S3b: Interaction of the FTO
gene polymorphism (rs8050136) with physical activity level on waist
circumference. The ‘A’ allele carriers who are physically inactive have
2.90cm higher waist circumference compared to those with ‘C’ allele
carriers (P = 2 × 10-4). Figure S3c: Interaction of the FTO gene
polymorphism (rs8050136) with physical activity level on obesity. The ‘A’
allele carriers who are physically inactive have 1.89 times increased risk of
obesity compared to those with ‘C’ allele carriers
(P = 4 x 10-5). *Odds ratio adjusted age, gender and Type 2 diabetes.
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